Endocannabinoid palmitoylethanolamide (PEA) ( DrugBank: Palmitoylethanolamide )

---

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
2	筋萎縮性側索硬化症	1

2. 筋萎縮性側索硬化症

---

臨床試験数 : 624 /  薬物数 : 611 - (DrugBank : 160) / 標的遺伝子数 : 172 - 標的パスウェイ数 : 225

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02645461 (ClinicalTrials.gov)	January 2014	22/12/2015	Acetylcholine Receptors From Human Muscles as Pharmacological Target for ALS	Acetylcholine Receptors From Human Muscles as Pharmacological Target for ALS	Amyotrophic Lateral Sclerosis	Drug: endocannabinoid palmitoylethanolamide (PEA);Drug: Riluzole	University of Roma La Sapienza	NULL	Completed	18 Years	N/A	Both	50	N/A	NULL